Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Sep;24(3):324–329. doi: 10.1128/jcm.24.3.324-329.1986

Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.

R W Hankins, F L Black
PMCID: PMC268906  PMID: 3531224

Abstract

A version of the Western blot was developed to detect serum antibodies against measles virus polypeptides. With this technique, a seroepidemiological survey of antibodies to the several measles virus proteins in diverse measles-related conditions was conducted. The sera were obtained from individuals with a recent or long-past history of natural measles, from persons with a history of immunization with live attenuated measles vaccine, and from patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles. The findings indicated that live attenuated measles vaccine elicits an antibody response qualitatively resembling that of a natural infection. In addition, multiple sclerosis patients made less antibody to the measles virus M protein than did individuals with a long-past history of natural measles. Thus, the immunological reaction of multiple sclerosis patients to measles virus is qualitatively, as well as quantitatively, different from that of normal persons. Finally, persons with subacute sclerosing panencephalitis and atypical measles mounted abnormally high antibody responses to measles virus polypeptides, in particular the P protein.

Full text

PDF
324

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS J. M., IMAGAWA D. T. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med. 1962 Dec;111:562–566. doi: 10.3181/00379727-111-27855. [DOI] [PubMed] [Google Scholar]
  2. Aaby P., Bukh J., Lisse I. M., Smits A. J. Measles mortality, state of nutrition, and family structure: a community study from Guinea-Bissau. J Infect Dis. 1983 Apr;147(4):693–701. doi: 10.1093/infdis/147.4.693. [DOI] [PubMed] [Google Scholar]
  3. Alter M., Leibowitz U., Speer J. Risk of multiple sclerosis related to age at immigration to Israel. Arch Neurol. 1966 Sep;15(3):234–237. doi: 10.1001/archneur.1966.00470150012002. [DOI] [PubMed] [Google Scholar]
  4. BECH V. Studies on the development of complement fixing antibodies in measles patients. Observations during a measles epidemic in Greenland. J Immunol. 1959 Sep;83:267–275. [PubMed] [Google Scholar]
  5. BLACK F. L., ROSEN L. Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure. J Immunol. 1962 Jun;88:725–731. [PubMed] [Google Scholar]
  6. Black F. L., Gudnadóttir M. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children. Bull World Health Organ. 1966;35(6):955–957. [PMC free article] [PubMed] [Google Scholar]
  7. Cockburn W. C., Pecenka J., Sundaresan T. WHO-supported comparative studies of attenuated live measles virus vaccines. Bull World Health Organ. 1966;34(2):223–231. [PMC free article] [PubMed] [Google Scholar]
  8. Dean G., Kurtzke J. F. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J. 1971 Sep 25;3(5777):725–729. doi: 10.1136/bmj.3.5777.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Detels R., Visscher B. R., Haile R. W., Malmgren R. M., Dudley J. P., Coulson A. H. Multiple sclerosis and age at migration. Am J Epidemiol. 1978 Nov;108(5):386–393. doi: 10.1093/oxfordjournals.aje.a112636. [DOI] [PubMed] [Google Scholar]
  10. GUDNADOTTIR M., BLACK F. L. RESPONSE OF ADULTS IN ICELAND TO LIVE ATTENUATED MEASLES VACCINE. Bull World Health Organ. 1964;30:753–762. [PMC free article] [PubMed] [Google Scholar]
  11. Giraudon P., Wild T. F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 1985 Jul 15;144(1):46–58. doi: 10.1016/0042-6822(85)90303-4. [DOI] [PubMed] [Google Scholar]
  12. Haire M. Significance of virus antibodies in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):40–44. doi: 10.1093/oxfordjournals.bmb.a071394. [DOI] [PubMed] [Google Scholar]
  13. Hall W. W., Lamb R. A., Choppin P. W. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2047–2051. doi: 10.1073/pnas.76.4.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hayes E. C., Gollobin S. D., Machamer C. E., Westfall L. K., Zweerink H. J. Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosis. Infect Immun. 1980 Mar;27(3):1033–1037. doi: 10.1128/iai.27.3.1033-1037.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Krugman S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr. 1977 Jan;90(1):1–12. doi: 10.1016/s0022-3476(77)80755-5. [DOI] [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Larke R. P. Impact of measles in Canada. Rev Infect Dis. 1983 May-Jun;5(3):445–451. doi: 10.1093/clinids/5.3.445. [DOI] [PubMed] [Google Scholar]
  18. Merril C. R., Goldman D., Sedman S. A., Ebert M. H. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science. 1981 Mar 27;211(4489):1437–1438. doi: 10.1126/science.6162199. [DOI] [PubMed] [Google Scholar]
  19. Merz D. C., Scheid A., Choppin P. W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980 Feb 1;151(2):275–288. doi: 10.1084/jem.151.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Morgan E. M., Rapp F. Measles virus and its associated diseases. Bacteriol Rev. 1977 Sep;41(3):636–666. doi: 10.1128/br.41.3.636-666.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Norrby E., Kristensson K., Brzosko W. J., Kapsenberg J. G. Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis. J Virol. 1985 Oct;56(1):337–340. doi: 10.1128/jvi.56.1.337-340.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Norrby E., Link H., Olsson J. E., Panelius M., Salmi A., Vandvik B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun. 1974 Oct;10(4):688–694. doi: 10.1128/iai.10.4.688-694.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Norrby E., Orvell C., Vandvik B., Cherry J. D. Antibodies against measles virus polypeptides in different disease conditions. Infect Immun. 1981 Dec;34(3):718–724. doi: 10.1128/iai.34.3.718-724.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ohara Y., Tashiro M., Takase S., Homma M. Detection of antibody to M protein of measles virus in patients with subacute sclerosing panencephalitis: a comparative study on immunoprecipitation. Microbiol Immunol. 1985;29(8):709–723. doi: 10.1111/j.1348-0421.1985.tb00875.x. [DOI] [PubMed] [Google Scholar]
  25. Rima B. K. The proteins of morbilliviruses. J Gen Virol. 1983 Jun;64(Pt 6):1205–1219. doi: 10.1099/0022-1317-64-6-1205. [DOI] [PubMed] [Google Scholar]
  26. Rozenblatt S., Gesang C., Lavie V., Neumann F. S. Cloning and characterization of DNA complementary to the measles virus mRNA encoding hemagglutinin and matrix protein. J Virol. 1982 Jun;42(3):790–797. doi: 10.1128/jvi.42.3.790-797.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Salmi A., Gollmar Y., Norrby E., Panelius M. Antibodies against three different structural components of measles virus in patients with multiple sclerosis, their siblings and matched controls. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Oct;81(5):627–634. doi: 10.1111/j.1699-0463.1973.tb02253.x. [DOI] [PubMed] [Google Scholar]
  28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Visscher B. R., Detels R., Coulson A. H., Malmgren R. M., Dudley J. P. Latitude, migration, and the prevalence of multiple sclerosis. Am J Epidemiol. 1977 Dec;106(6):470–475. doi: 10.1093/oxfordjournals.aje.a112493. [DOI] [PubMed] [Google Scholar]
  30. Wechsler S. L., Meissner H. C. Elevated antibody levels against measles virus P protein in sera of patients with multiple sclerosis. Infect Immun. 1983 Jun;40(3):1226–1229. doi: 10.1128/iai.40.3.1226-1229.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wechsler S. L., Weiner H. L., Fields B. N. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol. 1979 Aug;123(2):884–889. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES